Form 10-Q · Quarterly report
Colgate-Palmolive 10-Q, filed Jul 31, 2026
- Filed
- CIK
- 0000021665
- Accession no.
- 0000021665-26-000042
Summary
Colgate-Palmolive reported second-quarter 2026 net sales of $5.36 billion, up from $5.11 billion a year earlier, while net income attributable to the company fell to $693 million from $743 million and diluted earnings per share slipped to $0.86 from $0.91. For the first six months of 2026, net sales were $10.69 billion and net income attributable to the company was $1.34 billion, down from $1.43 billion a year earlier.
Key points
- Operating profit for the quarter fell to $1.02 billion from $1.08 billion a year earlier, as selling, general and administrative expenses rose to $2.13 billion from $1.96 billion.
- The company paid dividends of $0.53 per common share during the quarter and $1.06 per share over the six months.
- Long-term debt was $7.82 billion at June 30, 2026, compared with $6.87 billion at December 31, 2025, while cash and cash equivalents were $1.37 billion.
- Net cash provided by operations for the six months was $1.74 billion, up from $1.48 billion a year earlier.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
k Exchange 0.875% Notes due 2039 CL39 New York Stock Exchange Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.